oxbryta pfizer news - Search News

Pfizer withdraws sickle cell drug Oxbryta

sicklecellanemianews · 23h

Pfizer withdraws Oxbryta from global markets, cites safety concerns

Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.

The Wall Street Journal on MSN · 6d

Pfizer to Withdraw Sickle Cell Drug Oxbryta Lots from World-Wide Markets

The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the approved sickle cell patient population.

biznews.com · 3d

Pfizer pulls sickle cell drug oxbryta, raising safety concerns

Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.

BMS’ Schizophrenia Approval, Pfizer’s Sudden Sickle Cell Withdrawal and Roche’s Pharma Day

Bristol Myers Squibb wins approval for the first novel schizophrenia drug in decades; Pfizer pulls Oxbryta from the market; ...

2d

Pfizer starts voluntary withdrawal of OXBRYTA, benefit does not outweigh risks

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

6d

Pfizer to Withdraw Sickle-Cell Drug Oxbryta From Worldwide Markets

The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the ...

Current Updates: Major Developments in Health Sector

This summary highlights major health news, including Bavarian Nordic's UNICEF agreement for mpox vaccines, Pfizer's ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results